Nanopublications LDF server

Matches in Nanopublications for { <http://www.w3.org/2000/01/rdf-schema#SENTENCE> ?p ?o ?g. }

• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." provenance.
• SENTENCE label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." provenance.
• SENTENCE label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." provenance.
• SENTENCE label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." provenance.
• SENTENCE label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "The average mass loads of PGE2 and 5-iPF2&#945;-VI in a community were significantly increased (two-tailed p < 0.001) from the first month of COVID-19 pandemic to the second month; however, significantly decreased (two-tailed p < 0.001) in the third month." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "In the mechanically-ventilated COVID-19 population, treatment with dexamethasone showed significant protection against mortality (single study)." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.
• SENTENCE label "AA (arachidonic acid) is the precursor of both prostaglandin E2 (PGE2) and LXA4 suggesting that AA (arachidonic acid) is most suited for such preventive and therapeutic approach." provenance.

• first
• previous
• next